Quest Patent Research Corporation reports a difficult first quarter of 2026, with no revenue and a net loss of $2,936,337, or $0.55 per share. Litigation and licensing expenses rose sharply to $1,710,171, mainly tied to the MR patent portfolio, while selling, general and administrative costs were $1,117,963.
Cash increased to $619,861, but current liabilities reached about $30.2M, including funding liabilities of $24.8M owed to QF3 and QPRC Finance. The company ended the quarter with an accumulated deficit of roughly $37.8M and negative working capital of about $29.6M. Management states these factors raise substantial doubt about its ability to continue as a going concern, given its history of losses, lack of recent revenue, and dependence on successful patent litigation and third-party financing.
Quest Patent Research Corporation filed a Post-Effective Amendment to its Form S-1 to register 1,000,000 shares of common stock for resale by selling stockholders. The prospectus states the company will receive no proceeds from these sales. The offering comprises 500,000 currently owned shares and 500,000 shares issuable upon exercise of a warrant.
The prospectus discloses financial context including 5,331,973 shares outstanding, a last reported OTCQB price of $0.20 per share (May 7, 2026), and recent operating losses (net loss $8,491,508 for 2025). The filing emphasizes material risks: a working capital deficiency, substantial doubt about going concern, dependence on third‑party litigation funding, and concentrated governance and operational resources.
Quest Patent Research Corporation files its annual report describing a small, litigation-driven patent monetization business facing significant financial strain. The company manages 24 intellectual property portfolios, actively pursuing licensing and infringement lawsuits, with all licensing revenue to date arising from litigation-based settlements.
Since 2008, Quest has generated approximately $39.8 million of cumulative revenue but incurred about $34.9 million of cumulative losses and ended 2025 with total assets near $10.4 million and a working capital deficiency of roughly $27.2 million. Auditors included a going concern paragraph, reflecting doubts about its ability to continue operating without additional funding.
Operations depend on complex, largely non‑recourse financing from QPRC Finance, QF3, QFL and Intelligent Partners, who receive priority rights to cash flows from key patent portfolios. The company’s sole full‑time executive, CEO Jon Scahill, leads all sourcing, due diligence and enforcement efforts, underscoring key person risk as it continues aggressive patent litigation in U.S. federal courts.
Quest Patent Research Corporation reported Q3 2025 results with no revenue and a net loss of $1,230,309 (loss per share $0.23). Selling, general and administrative expenses were $1,011,617 and net other expense was $218,692, including interest expense of $177,787.
For the nine months ended September 30, 2025, the company recorded a net loss of $3,196,485. Cash was $175,141 and current assets totaled $194,432 against current liabilities of $22,706,870, reflecting a negative working capital of about $22,512,000. Management disclosed that these conditions raise substantial doubt about the company’s ability to continue as a going concern.
Total assets rose to $11,012,559 driven by patents of $10,818,127 after MR Licensing purchased a patent portfolio for $9,000,000 funded by QPRC Finance. Funding liabilities were $17,798,856 (QPRC Finance and QF3). Shares outstanding were 5,331,973 as of November 13, 2025.